Innate Pharma IPHA
NASDAQ IPHA
$2.26 +0.17 (+8.25%)
As of: Aug 21, 2026 · 3:17 PM EDT

Innate Pharma (IPHA) Net Margin Growth (3y) (2022 - 2024)

Innate Pharma (IPHA) Net Margin Growth (3y) (2022 - 2024) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 138.93 Bn 131.07 Bn 2.84 Bn -374.00
2 Regeneron Pharmaceuticals 85.91 Bn 77.92 Bn 3.93 Bn -44.00
3 Argenx Se 64.98 Bn 59.80 Bn 1.37 Bn -389.00
4 Moderna 58.86 Bn 53.72 Bn 52.00 Mn -13,815.00
5 BeOne Medicines 42.03 Bn 36.93 Bn 1.53 Bn 7,793.00
6 Alnylam Pharmaceuticals 31.54 Bn 28.23 Bn 992.69 Mn 9,934.00
7 BioNTech SE 27.88 Bn 9.49 Bn 668.28 Mn -11,156.00
8 Insmed 27.44 Bn 26.28 Bn 358.27 Mn 31,387.00
9 Royalty Pharma 27.35 Bn 26.51 Bn - -5,319.00
10 Innate Pharma 202.48 Mn 202.48 Mn - -176,448.00

Historic Data

Download Data
DateValue
Dec 31, 2024 -127,900.00
Dec 31, 2023 9,788.00
Dec 31, 2022 3,021.00